Pacific Biosciences of California, Inc. - PACB

SEC FilingsOur PACB Tweets

About Gravity Analytica

Recent News

  • 09.11.2025 - 2025 Microbiome SMRT Grant Awardees
  • 09.04.2025 - Powered by PacBio: Selected publications from August 2025
  • 09.03.2025 - PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
  • 08.28.2025 - Looking to make sense of your research? There’s HiFi for that
  • 08.20.2025 - Fast-track biopharma breakthroughs with HiFi long-read sequencing
  • 08.14.2025 - Sequencing 101: How multiplexing with long-read sequencing makes genomic research faster, cheaper, and smarter
  • 08.08.2025 - Powered by PacBio: Selected publications from July 2025
  • 08.07.2025 - PacBio Announces Second Quarter 2025 Financial Results
  • 08.06.2025 - PacBio to Present at Upcoming Investor Conferences
  • 08.04.2025 - Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

Recent Filings

  • 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.18.2025 - 144 Report of proposed sale of securities
  • 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.07.2025 - EX-99.1 EX-99.1
  • 08.07.2025 - S-8 Securities to be offered to employees in employee benefit plans
  • 08.07.2025 - 8-K Current report
  • 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]